CME
56
-3
NEM
50
2
HAS
37
-4
DNB
58
-2
WBA
60
-6
RIG
54
7
MRK
25
-5
AVY
51
-2
M
50
-3
RHI
59
2
DD
55
2
AVB
57
2
AMP
54
2
LEN
46
-3
PPG
60
-4
ITW
58
-4
EIX
62
-4
MCK
52
-3
SYF
86
3
VFC
56
3
CME
56
-3
NEM
50
2
HAS
37
-4
DNB
58
-2
WBA
60
-6
RIG
54
7
MRK
25
-5
AVY
51
-2
M
50
-3
RHI
59
2
DD
55
2
AVB
57
2
AMP
54
2
LEN
46
-3
PPG
60
-4
ITW
58
-4
EIX
62
-4
MCK
52
-3
SYF
86
3
VFC
56
3
Financhill
Back

Orchestra BioMed Holdings Quote, Financials, Valuation and Earnings

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Sell
49

OBIO
Orchestra BioMed Holdings

Last Price:
5.33
Seasonality Move:
4.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Better Than Oil Stocks

CLICK HERE TO FIND OUT MORE

Orchestra BioMed Holdings Price Quote

$5.33
-0.02 (-0.37%)
(Updated: December 12, 2024 at 5:55 PM ET)

Orchestra BioMed Holdings Key Stats

Sell
49
Orchestra BioMed Holdings (OBIO) is a Sell
Day range:
$5.21 - $5.75
52-week range:
$4.22 - $11.69
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
72.93
P/B ratio:
4.38%
Volume:
51.5K
Avg. volume:
62.2K
1-year change:
-28.48%
Market cap:
$202.4M
Revenue:
$2.8M
EPS:
$-1.61

How Much Does Orchestra BioMed Holdings Make?

Is Orchestra BioMed Holdings Growing As A Company?

Orchestra BioMed Holdings Stock Price Performance

What Is Orchestra BioMed Holdings 52-Week High & Low?

Orchestra BioMed Holdings Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Orchestra BioMed Holdings?

Is Orchestra BioMed Holdings Cash Flow Positive?

  • What Is OBIO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$48M
  • What Is Orchestra BioMed Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $4.5M
  • What Is Orchestra BioMed Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $50M

Orchestra BioMed Holdings Return On Invested Capital

  • Is Management Doing A Good Job?
    OBIO return on invested capital is -94.62%
  • What Is Orchestra BioMed Holdings Return On Assets?
    ROA measures how assets are converting to revenues and is -65.27%
  • What Is OBIO Return On Equity?
    ROE is a measure of profitability and is -97.7%

Orchestra BioMed Holdings Earnings Date & Stock Price

Orchestra BioMed Holdings Competitors

Orchestra BioMed Holdings Dividend Yield

Orchestra BioMed Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 7.35%
Revenue: 135.56% 38.72%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 15.60
Upside from Last Price: 191.59%

Major Shareholders

  • How many OBIO shares are owned by institutional investors?
    31.7M OBIO shares are owned by institutional investors
  • How many OBIO shares are owned by insiders?
    2.5M OBIO shares are owned by insiders